Property Of Solids (Part 2) PDF
Document Details
Uploaded by AttentiveEarth
LECOM School of Pharmacy
Dr. Yang
Tags
Summary
This document contains questions regarding the various properties of solids, including topics like the Stokes-Einstein equation, differential scanning calorimetry (DSC), and thermogravimetric analysis (TGA).
Full Transcript
PROPERTY OF SOLIDS (PART 2) – DR. YANG 1. What is the Stokes-Einstein equation used for? A: It relates the diffusion coefficient of a particle to its size and the viscosity of the solvent. 2. What is the principle behind Differential Scanning Calorimetry (DSC)? A: It measures the difference in h...
PROPERTY OF SOLIDS (PART 2) – DR. YANG 1. What is the Stokes-Einstein equation used for? A: It relates the diffusion coefficient of a particle to its size and the viscosity of the solvent. 2. What is the principle behind Differential Scanning Calorimetry (DSC)? A: It measures the difference in heat required to raise the temperature of a sample and a reference as a function of temperature. 3. What is Thermogravimetric Analysis (TGA) used for? A: It determines material properties by measuring mass changes due to decomposition, oxidation, or moisture loss. 4. What does Thermomechanical Analysis (TMA) measure? A: Changes in the dimension or mechanical properties of a sample as a function of temperature. 5. What is melting point depression? A: It occurs when impurities lower the melting point of a compound, broadening the melting range. 6. What is eutectification? A: The process of forming a eutectic mixture, where the melting point of the mixture is lower than that of the individual components. 7. Define polymorphism in materials science. A: The ability of a solid material to exist in more than one form or crystal structure. 8. What are enantiotrophs? A: Polymorphs that are stable at different pressures and temperatures. 9. What are monotrophs? A: Polymorphs where only one form is stable below the melting point. 10. What factors affect polymorphism? A: Temperature, humidity, solvents, grinding, photostability, and excipients. 11. How does temperature affect polymorphism? A: Temperature can induce transitions between polymorphic forms, affecting stability. 12. What is the role of humidity in polymorphism? A: Humidity can affect the stability and transition of polymorphic forms. 13. What are the techniques used to study polymorphism? A: Optical crystallography, hot stage microscopy, X-ray diffraction, FTIR, and microcalorimetry. 14. What is the significance of the refractive index (RI)? A: It describes how light propagates through a material and is used in optical crystallography. 15. What is Fourier Transform Infrared Spectroscopy (FTIR) used for in polymorphism studies? A: To obtain the infrared spectrum of a sample, aiding in polymorph identification. 16. What is pseudopolymorphism? A: The phenomenon where solvent molecules are incorporated into the crystal lattice, forming solvates. 17. What is the effect of impurities on melting point? A: Impurities lower the melting point and broaden the melting range of a compound. 18. How is the eutectic point defined? A: It is the lowest temperature at which a mixture of two compounds melts. 19. What is the melting point depression test used for? A: To identify compounds by mixing an unknown sample with a known compound and observing the melting behavior. 20. How does DSC distinguish between sample and reference? A: It measures the heat flow difference as temperature increases. 21. What is the function of TGA in pharmaceutical analysis? A: It helps analyze moisture content, decomposition, and other mass changes in drug substances. 22. What is a eutectic mixture and give an example? A: A mixture with a lower melting point than its components, e.g., lidocaine and prilocaine. 23. What is the role of TMA in pharmaceutical analysis? A: It measures changes in dimensions of materials, such as expansion or contraction due to temperature. 24. What is a binary eutectic phase diagram? A: It represents the relationship between temperature and composition for two substances forming a eutectic mixture. 25. What is the significance of crystal habits in polymorphs? A: Different crystal habits can affect the formulation and stability of pharmaceuticals. 26. How can polymorphism affect drug formulation? A: Polymorph transitions can cause changes in bioavailability, solubility, and stability. 27. What is the difference between metastable and stable polymorphs? A: Metastable polymorphs can convert to more stable forms over time. 28. What is the impact of polymorphism on suspension formulations? A: Polymorphic changes can alter particle size, leading to caking or instability in suspensions. 29. How does the presence of excipients influence polymorphism? A: Excipients can stabilize or destabilize polymorphs, affecting drug formulation. 30. What is the use of X-ray diffraction in polymorphism? A: It identifies crystal structures by analyzing the diffraction patterns of X-rays through a sample. 31. What is thermodilatometry? A: A technique that measures dimensional changes in a sample with minimal force applied, under temperature variation. 32. Why is grinding a factor in polymorphism? A: Grinding can induce polymorphic transitions by altering the crystal structure. 33. What is the function of FTIR in detecting polymorphs? A: FTIR provides a rapid qualitative and quantitative analysis of polymorphs based on their infrared absorption spectra. 34. How does the method of preparation affect polymorphism? A: Different preparation methods can result in distinct polymorphic forms with varying properties. 35. What is the transition temperature in polymorphs? A: The temperature at which one polymorph converts into another. 36. What does the heat of fusion represent in thermal analysis? A: The energy required to convert a solid into a liquid at its melting point. 37. How can polymorphism cause issues in suppository formulation? A: Changes in the polymorphic form of the base, like theobroma oil, can result in altered melting characteristics. 38. What are the effects of photostability on polymorphs? A: Exposure to light can cause polymorphic transitions, affecting drug stability. 39. What is the relevance of solubility in polymorphism? A: Different polymorphs have varying solubilities, which can impact drug absorption and bioavailability. 40. How is optical crystallography used in polymorphism screening? A: It examines crystal structures and the stability of metastable forms under different conditions. 41. What is the significance of pseudopolymorphs in drug formulation? A: Pseudopolymorphs, which incorporate solvent molecules, can alter the solubility and stability of drugs. 42. How can temperature and pressure affect polymorphic stability? A: Enantiotropic polymorphs are stable over different ranges of temperature and pressure, while monotrophic polymorphs have only one stable form. 43. What does microcalorimetry measure in polymorphism studies? A: It detects small heat changes during transitions between polymorphs, helping to characterize thermal behavior. 44. What are the benefits of using DSC in polymorphism studies? A: It provides information about the heat transitions between polymorphs and helps determine the melting points. 45. What is the significance of excipient incompatibility in polymorph stability? A: Incompatible excipients can destabilize polymorphs, leading to formulation failures. 46. What are the common applications of polymorphism in the pharmaceutical field? A: Polymorphism is used to optimize drug solubility, stability, and bioavailability. 47. What are solvates in the context of polymorphism? A: Solvates are crystals that include solvent molecules within their structure, influencing the physical properties of the solid. 48. How is the melting point related to the purity of a compound? A: A purer compound will have a narrower and higher melting point. 49. Why is polymorphism important for the drug Ritonavir? A: A polymorphic change caused the drug to become less bioavailable, impacting its therapeutic effectiveness. 50. What is the significance of particle size in polymorphism? A: Polymorphic transitions can cause changes in particle size, affecting drug dissolution and bioavailability.